Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MK-0954E in Japanese Patients With Essential Hypertension
NCT01299376Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of amlodipine + losartan potassium + hydrochlorothiazide in essential hypertension, sponsored by Merck & Co.. Started Jan 2011; status: completed.
02
Drugs
amlodipine + losartan potassium + hydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01299376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299376.